March 26, 2020: Lopinavir/ritonavir falls short against COVID-19; impact of PrEP scale-up on HIV diagnoses; long-term cost-effectiveness of various HIV interventions; disparities in virologic suppression among young people.
Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
Replacing group meetings and public outreach with telehealth consults, Zoom meet-ups, and food/med curbside deliveries are all part of the solutions.
June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.
HIV self-testing vs. professional HIV testing; the most effective influenza vaccine strategies for people with HIV; how age can affect flu vaccine efficacy; early HIV treatment and CD4:CD8 ratio normalization.
Flu season can bring anxiety for people living with HIV and their health care providers. But do HIV-positive people have more severe symptoms of flu than people who are not living with HIV? In this interview, Christina Schofield, M.D., shares her stu...
HIV (human immunodeficiency virus) is the virus that causes AIDS (acquired immune deficiency syndrome). HIV kills or damages cells in the body's immune system, gradually destroying the body's ability to fight infection and certain cancers. CDC estima...
More HIV-positive patients who were vaccinated against influenza early in the season got the flu compared to those vaccinated after mid-November, according to a study at IDWeek 2014, raising questions about whether timing of vaccination matters.
I was speaking with a British colleague the other day, and she was remarking how jealous she was that we get a Thanksgiving holiday each year. Starting with a long whine (or moan, as they would say) about the pressures, commercialization, cost, and r...
Fluzone High-Dose, approved by the U.S. Food and Drug Administration in 2009 for immunizing people 65 and older against the flu, is also effective in building a higher immune response among people with HIV, according to a U.S. study.